|
Bioidentical HRT was developed by various physicians in the early 1980’s. Most
practioners drew on their knowledge of biochemistry and the estrogen excretion
of fertile females, and developed unique treatment strategies for their
patients. Uniform BHRT dosing does not exist per say. There are various
experts in the field that have different philosophies on dosing and the cycling
of the hormones which other practitioners use as guidelines. Most physicians
use compounds of Biest or Triest. Biest contains 20% E2 and 80% E3.
Triest contains 10% E1, 10% E2 and 80% E3.
The Tale of Three Estrogens:
Estrone (E1) http://www.icgeb.org/~p450srv/ligand/estrone.gif

Estrone is widely used alone in commercial preparations such as Orth-Est and
Ogen. However, it is thought to be procarcinogenic in the breast and
endometrium at high doses. It is the largest component of Premarin (75-80% E1)2
Estradiol (E2) http://www.icgeb.org/~p450srv/ligand/estradiol.gif

Estradiol is the main estrogen secreted by the ovaries. Estradiol is also
widely used in commercial preparations such as Premarin. It has been shown to
protect against osteoporosis and cardiovascular disease and increase HDL. High
doses appear to stimulate carcinoma of the breast and endometrium and it should
be opposed by estriol2.
Estriol (E3) http://histoirechimie.free.fr/Estriol.gif
Estriol
is converted from estrone primarily in the liver. It is rapidly
metabolized and binds fleetingly to estrogen receptors. It and progesterone are
the hormones made in the greatest quantities during pregnancy. It has
always been considered a weak estrogen. There is some evidence that estriol is
antineoplastic or at least has less of a potential to cause cancer than E1
or E23.
Estriol does have advantages over other estrogens3
-
Better than estradiol to treat urinary tract infections
-
Most beneficial to the vagina, cervix, and vulva for vaginal
dryness treatment
-
Benefits of other estrogens witout the risks
-
Estriol leaves the body more quickly than estradiol and
estrone
-
Estriol is breast-tissue protective, not proliferative
2. Drisko, JA. Natural isomolecular hormone replacement: an evidence based
medicine approach. International Journal of Pharmaceutical Compounding vol.4
no.6, 2000.
3. Taylor, M. Unconventional Estrogens: Estriol, Biest, and Triest. Clinical
Obstetrics and gynecology vol.44 no.4 pp864-879, 2001
|